Tyler M. Thompson

Senior Advisor

Washington, D.C.
T +1.202.861.1571
F +1.202.861.1783

Overview

Tyler Thompson assists clients with regulatory, legislative and policy matters related to healthcare access to affordable pharmaceuticals and medical devices, and occupational and workplace safety. He was a top advisor to Senator Johnny Isakson and served in a number of positions in the United States Senate for over ten years, focusing primarily on healthcare and OSHA policy, as well as appropriations. Since leaving Capitol Hill in 2012, Tyler has served as a lead consultant to a diverse group of clients across numerous industries, including technology innovators, industrial manufacturers, pharmaceutical and medical device companies, nonprofit children’s hospitals, and major trade associations.

Through this work, Tyler forged strong relationships with key members and staff in House and Senate leadership, as well as relevant committees of jurisdiction in both chambers on both sides of the aisle and in the Administration. Tyler works thoughtfully in a bipartisan manner to bridge gaps between opposing viewpoints and employs a keen understanding of administrative and legislative procedures to provide informed strategic advice and effective execution on behalf of clients.

*Not an Attorney

Select Experience

  • Worked to reform Medicaid policy related to children’s healthcare needs through involvement in the Children’s Hospital Graduate Medical Education Reauthorization policy.
  • Represented clients in meetings and substantive work with OSHA and relevant committees on Capitol Hill to further their interests though regulatory and legislative processes.
  • Navigated policies and procedures while providing substantive work and strategic analysis of the Affordable Care Act for a key US Senator.
More »

Experience

  • Worked to reform Medicaid policy related to children’s healthcare needs through involvement in the Children’s Hospital Graduate Medical Education Reauthorization policy.
  • Represented clients in meetings and substantive work with OSHA and relevant committees on Capitol Hill to further their interests though regulatory and legislative processes.
  • Navigated policies and procedures while providing substantive work and strategic analysis of the Affordable Care Act for a key US Senator.
  • Collaborated with opposing viewpoints during discussions on the Hope Offered Through Principled and Ethical Stem Cell Research (HOPE) Act. Used strong communication to assist in development of policies that addressed interests of all parties on controversial topic.
  • Negotiated and compromised with opposing parties throughout development of the Drug Quality of Security Act.
  • Involved in development of legislative policies related to pharmaceutical and medical device industry, including the Prescription Drug User Fee Act, Medical Device User Fee Act, Animal Drug User Fee Act, Biologics Price and Competition Act, Pandemic and All-Hazards Preparedness Act, and Medicare Modernization Act. Used combined knowledge of policies and politics at play to advance specific interests while remaining sensitive to stances of opposing parties.
  • Advised Senators and healthcare industry clients on healthcare regulations and policies within the Department of Health and Human Services. Provided additional advice on healthcare issues concerning, among other things, CDC and NIH budget formulation and appropriations and OMB policy.

Recognitions and Memberships

Industries

Prior Positions

  • The Bockorny Group: Principal and Healthcare Practice Lead (2012 to 2013)
  • Legislative Assistant for United States Senator Johnny Isakson (2005 to 2012)
  • Legislative Correspondent for United States Senator Saxby Chambliss (2005)
  • Legislative Correspondent for United States Senator Zell Miller (2002 to 2005)

Admissions

  • [Not an Attorney]

Education

  • B.A., History, Sewanee: The University of the South, 2002

Blog

In The Blogs

Previous Next
Ohio Clock
The Future of SEC Enforcement Under the Biden Administration
By Kevin R. Edgar
April 19, 2021
With Gary Gensler confirmed as the new chairman of the Securities and Exchange Commission, the Democratic-run regulatory agency will prioritize policies that focus on investor and consumer protections. The Federal Policy team’s Kevin...
Read More ->
Ohio Clock
Democrats Face Key Test Vote on COVID-19 Relief Bill
By Christian B. Jones
February 22, 2021
House Democrats plan to vote as soon as Friday on their $1.9 trillion coronavirus relief bill, a key initial hurdle as they race to renew federal unemployment benefits, provide stimulus checks to millions of Americans and inject billions...
Read More ->
Ohio Clock
Daunting Deadlines: Congress' To-Do List on Expiring Laws
By Kevin R. Edgar
February 9, 2021
While Washington is rushing to enact COVID-19 funding before the mid-March expiration of enhanced federal unemployment benefits, lawmakers face a host of upcoming policy deadlines that will require congressional action. House and Senate...
Read More ->
Ohio Clock
Reconciliation Primer: Democrats March Toward COVID-19 Relief Bill
By Christian B. Jones
February 5, 2021
The Senate on Friday took the first step toward advancing filibuster-proof legislation that congressional Democrats hope to enact by mid-March that would include $1.9 trillion in COVID-19 relief and other policy priorities. Democrats are...
Read More ->
Ohio Clock
Congress Grants SEC New Authority in Securities Fraud Cases
By Christian B. Jones
January 4, 2021
Congress voted to give the Securities and Exchange Commission (SEC) sweeping new authority to prosecute violations by creating a 10-year statute of limitations for the agency to seek disgorgement of ill-gotten gains from securities fraud...
Read More ->